retatrutide fda approval status eli lilly will provide limited early access to its experimental obesity drug, retatrutide, for eligible patients before US approval. The expanded access program is aimed at adults with severe, treatment-resistant obesity Weight loss drug retatrutide use
Pay in 4 interest-free payments of $6.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26




























